Clinical Trials
63 trialsTissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
National Institutes of Health Clinical Center (CC)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
OvAR-Y
Washington University School of Medicine
National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute (NCI)
iCaRe2
University of Nebraska
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
University of Missouri-Columbia
CER
Cancer Support Community, Research and Training Institute, Philadelphia
TraveraRTGx
Travera Inc
Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
Zhejiang University
CAMPERR
Adela, Inc
PTC-IMPACT
Gene Solutions
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
University of Missouri-Columbia
DELFI-L101
Delfi Diagnostics Inc.
K-ACCELERATE
Gene Solutions
Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
Yonsei University
Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing
Tongji Hospital
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Genomic Testing and Resulting Medical Decisions
Arbeitsgemeinschaft medikamentoese Tumortherapie
PREFER
Labcorp Corporation of America Holdings, Inc
INSPIRE
Singlera Genomics Inc.
K-DETEK
Gene Solutions
FUTURE
Assistance Publique Hopitaux De Marseille
ROOT
Taproot Health
VCV
Mitera Hospital
Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and Treatment
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
SkinHealth
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
Zhujiang Hospital
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
Patient-Derived Xenografts to Reduce Cancer Health Disparities
University of California, Davis
Screening of Postoperative Pulmonary Complications by Electrical Impedance Tomography
Johannes Gutenberg University Mainz
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Fate Therapeutics
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Wuhan Ammunition Life-tech Co., Ltd
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Exact Sciences Corporation
Taiwan Cancer Moonshot Project
Academia Sinica, Taiwan
Artificial Intelligence System for Assessment of Tumor Risk and Diagnosis and Treatment
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
PASSION
Assistance Publique - Hôpitaux de Paris
Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients
Seoul National University Hospital
Effect of Multi-Media Tool on Enrollment in Oncology Clinical Trials
University of Chicago
Perceptions of Exceptional Patients in Cancer Care Relating to Their Unusual Survival
Meir Medical Center
PIONEER
SpeciCare
A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among Women
National Institutes of Health Clinical Center (CC)
WATTOX
Royal Marsden NHS Foundation Trust
Clinical Study on Raman Spectra of Blood, Saliva and Urine in Patients With Cancer Treated by Modern Therapy
The First Affiliated Hospital of Dalian Medical University
Study to Evaluate the Safety of Nanoxel M Inj.
Samyang Biopharmaceuticals Corporation
PIPACRegis
University of Magdeburg
An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors
Daiichi Sankyo
E-MOSAIC Electronic Tool to Monitor Symptoms
Swiss Cancer Institute
N1
CureOne
Circulating Tumor DNA Exposure in Peripheral Blood
Quantgene Inc.